PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Better regulation of mental health ‘therapies’ urgently needed to protect the vulnerable

2023-10-23
(Press-News.org) A rise in psychological pseudoscience is putting people at risk, psychologists have warned, with social media and celebrity endorsements partly to blame.

Mental health apps, mood-boosting supplements and energy therapies are among the therapies that could do ‘more harm than good’ according to psychologists Jonathan Stea and Stephen Hupp in their new book Investigating Clinical Psychology.

“As discourse around wellness, mental health, therapy, and access to these resources increasingly enter the public domain, the potential of coming across persuasive pseudoscience has also increased,” Stea explains.

“This is the age of health misinformation. It is everywhere. It is in our social media feeds, promoted by celebrities and influencers, and permeates the legacy news media. We are bombarded with advertisements pushing unsupported therapies and practices. Health misinformation has also worked its way into TV shows, movies, and books. And, increasingly, it is embraced and promoted by prominent politicians.”

Separating fact from fiction

Stea, Hupp and a slew of experts in the field have come together in a series of expert-led deep-dives into the world of clinical psychology with a focus on debunking and differentiating between pseudoscientific- and scientific approaches.

The book covers a variety of topics, including crystal healing, detoxing, animal-assisted therapies, hypnosis, and energy medicine.

“There have been many important contributions to clinical psychology that have flourished in the last century, but there has been an equally powerful but harmful rise in pseudoscience,” Hupp explains. “It is great that more people are talking about mental health – but it must be linked to scientific evidence.”

The authors and contributors give evidence to suggest pseudoscience causes direct harm – not only can it take vital time and money away from valid health provision, but it also erodes public trust in healthcare, besides having potentially detrimental effects on the patient themselves.

And the authors argue this is not a theoretical issue, as there are contemporary harmful and/or debunked therapies currently still in use – such as repressed memory practice and conversion therapy.

“If you think about this hypothetical journey, someone who is unwell may self-diagnose on social media with a condition not recognized by the medical community,” Stea says. “They may use a search engine to find out how to ‘treat’ said condition and encounter a scientifically implausible treatment.”

The book also gives historical examples of popular pseudoscientific psychology including primal scream therapy and psychoanalytical theories such as dream interpretation. It also explores the limits of popular psychological tools, like the Rorschach Inkblot Test, hypnotherapy, and the Myers-Briggs Personality Test, and questions the scientific rigor behind the eye-movement component of increasingly popular EMDR, despite considerable evidence supporting its overall efficacy.

The impact of popular culture

In the chapter supplied by Blake Boehme, Andres De Los Reyes, and Gordon Asmundson, they highlight how several professions with little or no mental health training have ‘injected themselves into the mental health landscape’.

They explain that people suffering from poorly understood or unexplained symptoms are particularly vulnerable, as they are desperate for an explanation for their condition and effective treatment.

“The symptoms and distress they experience are real and should be treated with compassion; however, compassion and exploitation should not be mistaken for one another,” they explain.

Some practitioners claim to hold knowledge about a condition that others do not and can gain a cult-like following, they suggest, gaining testimonials from supporters despite a lack of tangible evidence that the cure is accurate and effective.

“The new diagnosis becomes diagnosis du jour, often replacing or displacing the previous diagnosis, with information communications infrastructure (e.g., internet search engines) playing a crucial role in the rapidity of the spread,” they explain.

The authors describe how celebrities have publicly announced their diagnoses by practitioners who treat their conditions with unscientific methods, such as herbal remedies.

“A potent form of anecdote is now derived from celebrities or social media personalities,” they explain. “This anecdotal evidence is spread quickly by modern social media networks and can be subject to a continuous process of manipulation and revision as it spreads from person to person. An individual’s understanding of scientific principles can make them more or less likely to be manipulated by online pseudoscientific claims.”

‘Raising the bar’

To counter this rise in pseudoscience, the book suggests firmer regulation of mental health services and better-quality scientific studies into the efficacy of popular treatment. They endorse a system by which treatments cannot be offered to the public unless they meet strict criteria, including consistent results across large amounts of studies which demonstrate functional outcomes and lasting effects.

Further recommendations in the book include improving science literacy among the public and making health misinformation part of school curriculum so people know what to look out for.

The book’s editors also arm its readers with ‘signs’ of pseudoscience, including those who reverse the burden of proof on skeptics rather than proponents, an absence of connectivity to the broader scientific literature, an over-reliance on testimonials and elevation of anecdotal evidence and use of obscurantist and science-y sounding language.

Hupp concludes: “People with mental health challenges deserve the best, evidence-based therapies such as the many variations of behavioral and cognitive therapies. Looking ahead, it’s time to raise the bar.”

END


ELSE PRESS RELEASES FROM THIS DATE:

Do people everywhere care less about their cats than their dogs?

2023-10-23
Do canines get more care? Some studies have suggested pet owners are less emotionally attached to and less willing to finance care for cats than dogs, possibly because of cats’ behavior: cats may be perceived as caring less about humans and needing less care in return. But these studies are often conducted on non-representative samples and don’t consider possible cultural differences in attitudes to pets. A team of scientists led by Dr Peter Sandøe of the University of Copenhagen decided to investigate further. “We and others have found that people are willing to spend much less on their cats than ...

Association for Molecular Pathology appoints Lauren S. Menser as Chief Executive Officer

2023-10-23
ROCKVILLE, Md. – Oct.  23, 2023 – The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today announced the appointment of Lauren S. Menser, CAE, as its Chief Executive Officer, effective January 3, 2024. Menser will succeed Mary Steele Williams, MNA, MT(ASCP)SM, CAE, after her retirement. AMP’s national search for a new executive leader was administered by an outside consulting firm and overseen by a diverse group of member volunteers. Menser has served AMP in various capacities for more than 17 years. Since 2016, she has served as Director of Strategic Development, ...

Predictors of opioid overdose after prescription for chronic pain

2023-10-23
A large study published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.230459 identified 10 predictors of opioid overdose after prescription for chronic pain, which can help clinicians engage in shared decision-making with patients around opioid prescribing. “The opioid crisis has generated interest in identifying patients at higher risk of addiction or overdose and has led to the development of several screening tools; however, these instruments have either not been validated or shown poor psychometric properties,” writes Dr. Li Wang, a researcher and methodologist at the ...

Plant-based isn't just about burgers anymore

Plant-based isnt just about burgers anymore
2023-10-23
A team of University of Waterloo researchers has created smart, advanced materials that will be the building blocks for a future generation of soft medical microrobots.  These tiny robots have the potential to conduct medical procedures, such as biopsy, and cell and tissue transport, in a minimally invasive fashion. They can move through confined and flooded environments, like the human body, and deliver delicate and light cargo, such as cells or tissues, to a target position. The tiny soft robots are a maximum of one centimetre long and are bio-compatible and non-toxic. The robots are made of advanced hydrogel ...

Better use of existing drugs increases cervical cancer survival and reduces recurrence

2023-10-22
The INTERLACE phase III trial, funded by Cancer Research UK and UCL Cancer Trials Centre, assessed whether a short course of induction chemotherapy (IC) prior to chemoradiation (CRT) could reduce the rate of relapse and death among patients with locally advanced cervical cancer. As part of an analysis of clinical data, the preliminary results will be presented at the European Society for Medical Oncology (ESMO) congress on Sunday 22 October 2023. The peak incidence of cervical cancer is in women in their early thirties, with around 3,200 new cases each year in the UK. CRT has been the standard treatment for cervical cancer since 1999, but despite improvements ...

Adding immunotherapy to chemotherapy regimen improves survival in metastatic bladder cancer patients

2023-10-22
New York, NY (October 22, 2023) — A clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy with immunotherapy resulted in improved survival in patients with an advanced type of bladder cancer. The results were simultaneously reported in The New England Journal of Medicine and at the annual meeting of the European Society for Medical Oncology. The randomized phase 3 trial, named ”CheckMate 901,” showed significantly improved outcomes in patients who received the immunotherapy nivolumab with a combination of the chemotherapies gemcitabine and cisplatin, ...

Dual-action drug produces positive results in patients with advanced neuroendocrine tumors, trial finds

2023-10-22
Cabozantinib, which targets tumor cell growth and tumor blood vessel growth, sharply improved progression-free survival over placebo in patients with extra-pancreatic and pancreatic neuroendocrine tumors Boston - A drug that simultaneously strikes cancer cells' growth circuits and pipeline to the bloodstream produced encouraging results in a clinical trial involving patients with advanced neuroendocrine tumors, according to a study led by Dana-Farber Cancer Institute investigators. Jennifer Chan, MD, MPH, director of the Program ...

Alliance presents detailed results from phase III CABINET pivotal Trial evaluating cabozantinib in advanced neuroendocrine tumors at ESMO 2023

Alliance presents detailed results from phase III CABINET pivotal Trial evaluating cabozantinib in advanced neuroendocrine tumors at ESMO 2023
2023-10-22
The Alliance for Clinical Trials in Oncology today announced detailed results will be presented at ESMO 2023 from CABINET (A021602), a phase III pivotal trial evaluating cabozantinib compared with placebo in two cohorts of patients with previously treated neuroendocrine tumors: one cohort of patients with advanced pancreatic neuroendocrine tumors (pNET) and a second cohort of patients with advanced extra-pancreatic NET (epNET). The study met the primary objective for each cohort, demonstrating that cabozantinib provided dramatic improvements in median progression-free survival (PFS) for the patients in the pNET and epNET cohorts. ...

ESMO: Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer

ESMO: Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer
2023-10-21
MADRID ― Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer (NSCLC). Results from the Phase III CheckMate 77T study were presented today at the 2023 European Society for Medical Oncology (ESMO) Congress by researchers from The University of Texas MD Anderson Cancer Center. At a median follow-up of 25.4 months, the median EFS with chemotherapy alone was 18.4 months, while the median had not yet been reached for patients receiving perioperative nivolumab, meaning EFS was prolonged ...

Kidney cancer study shows improved outcomes for patients with advanced disease when treated with belzutifan over everolimus

2023-10-21
Boston – Belzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer, in patients previously treated with immune checkpoint inhibitors and anti-angiogenic therapies compared with everolimus in a phase 3 clinical trial. The trial, led by Toni K. Choueiri, MD, Director of the Lank Center for Genitourinary Cancer at Dana-Farber Cancer Institute, showed the risk of progression was reduced by 25-26%. The results were presented at the annual European Society for Medical Oncology (ESMO) Congress on October ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Better regulation of mental health ‘therapies’ urgently needed to protect the vulnerable